At a glance
- Originator Nonindustrial source
- Class Antineoplastics
- Mechanism of Action Alkylating agents; DNA cross linking agents
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Cancer
Most Recent Events
- 23 Feb 2000 No-Development-Reported for Cancer in United Kingdom (Unknown route)
- 31 Jan 1997 New profile
- 31 Jan 1997 Preclinical development for Cancer in United Kingdom (Unknown route)